Cerebral Venous Sinus Thrombosis in Women: Subgroup Analysis of the VENOST Study.
Derya UluduzSevki SahinTaskin DumanSerefnur OzturkVildan YaylaNazire AfşarNevzat UzunerIpek Gursoy MidiNilgun CinarMehmet Ali SungurFusun Mayda DomacBirsen InceBaki GoksanCemile Handan MisirliMustafa BakarHasan Huseyin KozakSena ColakogluAli Yavuz KarahanEylem Ozaydin GoksuFatih OzdagMehmet Guney SenolVedat Ali YurekliUfuk AlucluSerkan DemirHayriye KucukogluSerdar OrucNilufer YesilotOzge Yimaz KusbeciBijen NazlielFirdevs Ezgi Ucan TokucHesna BektasFatma Nida TascilarEmrah AytacMustafa GokceHale Zeynep Batur CaglayanAhmet TufekciGulnur UzunerDilek Necioglu OrkenOsman Ozgur YalinUygar UtkuArda YilmazHamit GencMurat CabalarAysel MilanliogluHakan EkmekciBurcu ZeydanSevim BaybasYuksel KablanBasak Karakurum GokselMustafa AcikgozHatice KurucuSeden DemirciTaskin GunesPublished in: Stroke research and treatment (2020)
The results of our study indicate that the risk of CSVT increases parallel to age, OC use, and puerperium period. In addition, when considering the frequency of findings and symptoms, epileptic seizures in the puerperium subgroup of the RHRF (+) group and malignancies in the RHRF (-) group may accompany the CSVT. In daily practice, predicting these risks for the CSVT and early recognition of the symptoms will provide significant benefits to patients.
Keyphrases
- end stage renal disease
- healthcare
- primary care
- chronic kidney disease
- newly diagnosed
- physical activity
- clinical trial
- polycystic ovary syndrome
- randomized controlled trial
- subarachnoid hemorrhage
- metabolic syndrome
- peritoneal dialysis
- quality improvement
- adipose tissue
- skeletal muscle
- brain injury
- patient reported outcomes
- insulin resistance
- human health
- cerebral ischemia
- double blind